Insulin resistance is a metabolic state in which cells respond poorly to insulin, so glucose uptake in muscle and fat is impaired and the liver continues to produce glucose despite high blood sugar. The pancreas compensates by secreting more insulin, leading to chronic hyperinsulinemia. Over time this imbalance contributes to type 2 diabetes, fatty liver disease, cardiovascular problems and other complications.

Research shows that excess calorie intake, especially from refined carbohydrates and saturated fats, visceral obesity and physical inactivity are key drivers. Enlarged and inflamed fat tissue releases inflammatory cytokines and free fatty acids, which disrupt insulin signaling pathways. Mitochondrial dysfunction, oxidative stress and ectopic fat accumulation in liver and muscle further impair insulin action. Genetics and early life factors modulate susceptibility, but lifestyle remains central.

Insulin resistance is closely tied to the metabolic syndrome, which includes abdominal obesity, high blood pressure, high triglycerides, low HDL cholesterol and elevated fasting glucose. Even before diabetes develops, insulin resistant individuals often have vascular dysfunction, increased blood clotting tendency and low grade inflammation, raising cardiovascular risk.

Intervention studies show that weight loss, regular aerobic and resistance exercise and dietary patterns rich in whole foods, fiber and unsaturated fats can markedly improve insulin sensitivity, sometimes normalizing blood sugar without drugs. Exercise enhances glucose uptake in muscle independently of insulin and improves mitochondrial function. Certain medications, such as metformin and thiazolidinediones, target hepatic glucose production or fat tissue function to lower insulin resistance, but lifestyle changes remain the foundation of prevention and treatment.